N/A N=83 A Clinical Trial of Splinting for DeQuervain's Tenosynovitis
DeQuervain's Tenosynovitis
Primary: Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire — 28; 29 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=32 Effectiveness of Astym Treatment For de Quervain's Tenosynovitis
de Quervain's Disease
Primary: Numeric Rating Scale for Pain — 3.2; 2.1 score on a scale
N/A N=64 Corticosteroid Injection for Common Upper Extremity Problems
Lateral Elbow Pain
Primary: Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire — 18; 13 units on a scale
N/A N=29 Percutaneous US Guided Elbow Tenotomy With the TenJet HydroSurgery System
Elbow, Tennis
Primary: Change in Elbow Pain Using Visual Analog Scale (VAS) — 5.1; 3.0; 1.9; 1.1 VAS Score
Phase 3 N=40 Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis
Arthritis
Primary: Numeric Pain Rating Scale — 1.7; 2.4; 3.2 units on a scale — p=0.6
N/A N=31 Thumb Osteoarthritis: A Cross-Sectional Study of Mechanisms
Carpometacarpal Osteoarthritis
Primary: Australian Canadian OA Hand Index (AUSCAN) — 3.3; 1.3; 2.0; 1.6 score on a scale
Phase 4 N=110 Trigger Finger Corticosteroid Injection With and Without Local Anesthetic
Trigger Finger
Primary: Pain Outcome: Visual Analog Scale — 3.5; 2 score on a scale
Phase 4 N=69 Long Term Effectiveness of Trigger Finger Injections With Triamcinolone vs. Dexamethasone
Trigger Finger Disorder
Primary: Number of Participants With no Symptoms of Trigger Finger — 28; 9 Participants
N/A N=26 Endoscopic Trigger Finger Release
Trigger Finger
Primary: Scar Comparison Between Treatment Arms, as Measured by the Patient and Observer Scar Assessment Scale (POSAS) — 27.2; 45.0; 31.2; 44.8 score on a scale — p=0.013
N/A N=29 4DCT Imaging for Improved Diagnosis and Treatment of Wrist Ligament Injuries
Scapholunate Interosseous Ligament Injury
Primary: Equivalency of 4DCT-based Treatment Plan to Arthroscopic-based Treatment Plan. — 5; 14; 11 Participants
Phase 2 N=56 CMC (Carpometacarpal) OA (Osteoarthritis) Thumb Splint Study
Osteoarthritis
Primary: Hand Function — 5.54; 2.69 units on a scale
N/A N=62 Factors Associated With Radiographic Pathophysiology for Trapeziometacarpal Arthrosis in Patients Not Seeking Care for This Condition
Trapeziometacarpal Arthrosis
Primary: Factors Associated With Eaton Classification of Trapeziometacarpal Arthrosis: Age — 61; 66; 75 Years
Phase 4 N=234 Injection Versus Splinting in Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS)
Primary: Symptom Severity and Limitations in Hand Function as Assessed by the BCTQ 6 Weeks — 2.02; 2.29 score on a scale — p=<0.001
N/A N=31 LRTI vs Internal Brace for CMC OA
Thumb Carpometacarpal Osteoarthritis
Primary: Postoperative Follow-Up Retention Rate — 17; 13; 0; 2 thumbs
N/A N=61 Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis
Thumb Osteoarthritis
Primary: Numeric Pain Rating Scale (NPRS) — 3; 3 units on a scale — p=0.87
N/A N=17 Dorsal Wrist Ganglia; Aspiration Alone vs Aspiration and Injection of Platelet Rich Plasma
Ganglion of Wrist
Primary: Number of Participants With a Recurrence of Ganglia — 8; 5 Participants
N/A N=32 An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study
Carpometacarpal Osteoarthritis
Primary: The Disabilities of the Arm, Shoulder and Hand Outcome Measure — 12.6 units on a scale
N/A N=90 Intra-articular Glucocorticoid Treatment of the Elbow
Rheumatoid Arthritis
Primary: Relapse of Arthritis — 8; 13; 44; 46 participants
N/A N=62 Cast Immobilization for Non-Displaced Scaphoid Fractures
Non-displaced Scaphoid Fractures
Primary: Extent of Union — 70; 85 percentage of union
N/A N=120 Comparison of Two Techniques for the Treatment of Carpal Tunnel Syndrome
Carpal Tunnel Syndrome
Primary: Incidence of Pillar Pain — 14; 24 Participants
Phase 2 N=140 Repurposing Anti-TNF for Treating Dupuytren's Disease
Dupuytren's Disease
Primary: Early Disease: Nodule Hardness at 12 Months — 58.1; 61.2 Durometer Arbitrary Units (AU)
N/A N=90 Digital Versus Conventional Physical Therapy for Chronic Shoulder Tendinopathy
Musculoskeletal Pain · Chronic Shoulder Pain · Shoulder Tendinopathy
Primary: Change in the Shortened Disabilities of the Arm, Shoulder and Hand Questionnaire (QuickDASH) — 15.5; 13.1 units on a scale — p=0.75
N/A N=13 Safety and Efficacy of a Novel Carpal Tunnel Tissue Manipulation Device in Treating Carpal Tunnel Syndrome
Carpal Tunnel Syndrome
Primary: Change in SSS of the BCTQ at 28 Days vs Baseline — 0.59; 0.93; .00 point decrease in SSS
Phase 2 N=21 Mechanisms of a Dynamic Stability Approach
Thumb Carpometacarpal Osteoarthritis · Thumb Basal Joint Osteoarthritis
Primary: Subluxation of Thumb Carpometacarpal Joint as Per CAT Scan — .66 millimeters
N/A N=94 Comparison of Occupational Therapy and Home Exercises for Adults With Operatively Treated Distal Radius Fractures
Distal Radius Fractures
Primary: Range of Motion in Degrees of the Wrists — 129; 118 Degrees
Phase 2 N=100 Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis
Lateral Epicondylitis
Primary: Elbow Pain Assessments (VAS), Treated Subjects — 76.6; 77.7; 75.9; 72 score on a scale
N/A N=33 Kinesiotaping in Lateral Epicondylitis
Lateral Epicondylitis
Primary: Patient Rated Tennis Elbow Evaluation (PRTEE) — 49; 53.75; 49.25; 26.5 units on a scale — p=0.643
Phase 2 N=96 Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy
Tendinopathy
Primary: The Western Ontario Rotator Cuff (WORC) Patient Reported Outcome (PRO) Score at Week 14 in All Patients - Statistical Analysis Results of Total WORC Scores at Week 14…
Phase 4 N=5 MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex
Dupuytren's Disease
Primary: The Measured Change in Volume of the Cord by MRI Before and After XIAFLEX Injection and Manual Manipulation. — 482 mm^3 — p=<0.0013
Phase 4 N=66 Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections
Trigger Finger
Primary: Incidence of Pain — 6; 11 Participants